The FDA labeled a recall of integrated arterial catheters made by Medline Class I, the most serious kind of recall.

Movano Health (Nasdaq:MOVE) announced today that it commenced a blood pressure clinical trial with its new cuffless wrist wearable.

Movano (MOVE) has commenced a blood pressure clinical trial with its newly developed cuffless blood pressure wrist wearable. The study, which ...

The accuracy study criteria for the comparisons between the systolic, diastolic, and MAP values from the noninvasive blood pressure monitor and the intra-arterial blood pressure reference standard ...

in patients with pulmonary arterial hypertension (PAH) — a rare disease caused by a constriction of arteries in the lungs, leading to high blood pressure. Keros said it observed excess fluid ...

A PaO2 test measures partial pressure of oxygen, or PaO2—the oxygen pressure in arterial ... stay or to monitor treatment or the progression of an illness. Drawing blood for this test takes ...

Study Finds Innovative Cuffless Blood Pressure Device Streamlines and Enhances Hypertension Management June 26, 2024 — A study evaluated a cuffless monitor that uses optical sensors to record ...

The company was testing the therapy, cibotercept, in patients with pulmonary arterial hypertension — a rare, progressive lung disease that causes high blood pressure in the pulmonary arteries.

F-FAPI PET -- can detect the first signs of tissue remodeling in patients with pulmonary arterial hypertension (PAH), providing physicians with an early marker for disease progression. This approach ...

Monitor Hgb before ... About PAH Pulmonary arterial hypertension (PAH) is a rare, progressive and life-threatening blood vessel disorder characterized by the constriction of small pulmonary arteries ...